Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| We're big believers that better beats first |
| And as you've seen most of the M&A and say like almost every M&A deal that's been out there has not been accretive and it's just looking and seeing will this be a good return |
| It's amazing |
| That's now scheduled for July, and we're really excited about that |
| But we're getting back to a point where it's, are we going to have enough supply, like, short term when we enter all these places? Products are doing well in all the markets we're in |
| And then there's some things that you wouldn't think of necessarily as traditional cost savings, but just overall working capital improvements led us to be up $20 million cash quarter-over-quarter, this Q4 |
| So starting with -- from the product up has been a big driver, right? And I think that has -- because we've done that with all the products, it has made the brand stronger and people then start to expect that from the brand |
| I think it's making sure we have the best products and when the market makes sense to enter |
| And I think we take share from the illicit market and make the industry successful |
| So I think we're in a good space |
| Things look great |
| The more we learn about consumers, the better we're able to meet their needs |
| And we have a great portfolio of products |
| I'm also cautiously optimistic that Canada will have had some changes, the ones that have been proposed around excise tax that I think makes it a much better market |
| If you talk about the illicit market, the best way to be able to compete with them is, give us the ability to leverage scale to be consistent |
| I think it's a big catalyst that we'd love to see happen |
| And after about four or five years, you start getting good results |
| But I would expect it will come and we will see brands that are great fits for us |
| So I think we're in pretty good shape, but always work to do, always something to optimize |
| Being able to keep the texture really great, it's just much different than a normal gummy and I think that's resonated |
| What I think does matter, what we're excited about is sort of near-term what's happening is being able to market cannabis |
| And if people don't know, I haven't looked this morning, but possibly trading with negative enterprise value, you've been very patient for a very long time |
| And so giving them comfort again, I think it's going to be important for patient growth |
| And we've actually seen rather than price compression with flour, there's actually opportunities to increase price |
| I think it serves us well |
| If we see other brands and products start to differentiate and something that we think would be better to buy versus build ourselves |
| So for Spinach, huge market share in gummies and edibles, and I think you've said it's now number one in flour |
| And the other is, we're happy to focus on organic growth |
| You look at New Zealand, UK, Czech Republic, Poland, those are really the best opportunities and only the kind of real markets today that I would think makes sense to enter |
| Allowing that to go into more pharmacies is going to be really, really important |
| Statement |
|---|
| In Canada, cannabis has gone through a multi-year period of oversupply, overproduction relative to demand |
| I can't predict where geopolitics go, but October was the worst month |
| There is a fear, especially in Israel |
| The first is, we've had this kind of, I'd just say, like lab testing issues where you had a lot of the smaller producers were lab shopping and sort of inflating THC results and that product was selling |
| I think the lack of capital in the industry, the fact that you've got 280E making R&D prohibitively expensive in the U.S |
| That's been a difficult thing for a lot of different type of CPG companies, going to different countries and having their brand resonate |
| Bill Kirk I mean, that sounds great, right? That has been a big problem for a long time, and it was most obvious at some of those value price points, right, if you will, right? That was where a lot of the competition was |
| Some of the largest players, they've lost a lot of share |
| And it's a shock to them |
| That's been another thing that there's been unsustainable supply in the market, people selling below their cost because effectively they weren't paying taxes |
| Last year, a few doctors were arrested for pay-to-play schemes |
| Very difficult |
| And I think it'd be just a distraction to try and move from that model |
| It's very difficult to just be a lifestyle brand in cannabis because the consumers really are focused on what is the product |
| I think the COVID, I think the Ukraine -- the Ukraine war, those actually slowed things down that were already moving |
| So yes, there's certainly a lot of fear post-opioid epidemic on what you're prescribing |
| It's not really high quality product |
| If you don't have a differentiated product, your brand is not really going to be differentiated |
| People wake up and realize, wow, the country didn't burn down when we allowed cannabis |
| But yes, you've got the UK, which you think is still somewhat influential |
Please consider a small donation if you think this website provides you with relevant information